Volume 14 Supplement 1
Promoting seamless transfer-of-care for stroke patients in primary care: development of the integrated care pathway for post stroke services
© Aziz et al; licensee BioMed Central Ltd. 2014
Published: 29 January 2014
Post-stroke care after hospital discharge suffers from lack of intersectoral collaboration within the public health sectors. Hence, primary care remains the only option in managing stroke patients in underserved areas in Malaysia. This study aimed to identify the areas, which can be better coordinated to deliver optimal post-stroke care in community setting. A seamless transfer of care model known as integrated Care Pathway for Post Stroke patients (iCaPPS) was designed to address this issue.
Materials and methods
Expert panel discussions comprising of family physicians, neurologists, rehabilitation physicians and therapists, and nurse managers from both Ministry of Health and the academia were conducted. Modified Delphi technique was employed to resolve practice variations through additional literature support. Care algorithms were designed around existing work schedules and available resources at public health centres.
Identified areas for coordinated transfer of care include: identification of patient criteria suitable for long-term stroke management at primary care facilities, information required at transfer of care, stroke risk factors treatment targets, screening for stroke complications and rehabilitation guide for primary care team. Care algorithm including appropriate tools were summarised to identify patients requiring further multidisciplinary rehabilitation interventions i.e. assessment for those uninitiated or missed out on rehabilitation and leisure intervention for those indicated, screening for swallowing disorders as well as mental health disorders (i.e. depression and dementia).
The iCaPPS would facilitate coordinated primary care-led post-stroke management for patients residing at home in the community, hence promoting better collaboration within public health sectors. Clinical outcomes and cost effectiveness of iCaPPS can be evaluated for benefit of stakeholders and stroke survivors.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.